HoldingsChannel.com
Aspen Aerogels insider buying image
The table below summarizes the most recent Aspen Aerogels insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Aspen Aerogels insider buys are important for investors to follow.
DateInsiderPriceAmount
9-7-2023
Insider Buy
Steven R. Mitchell
Director
$6.50
CAGR »
$49,008.96
7,541 shares
9-5-2023
Insider Buy
Steven R. Mitchell
Director
$6.17
CAGR »
$308,455.00
50,000 shares
8-22-2023
Insider Buy
Mark L. Noetzel
Director
$5.65
CAGR »
$22,581.20
4,000 shares
8-8-2023
Insider Buy
Donald R. Young
President and CEO
$6.83
CAGR »
$170,697.50
25,000 shares
12-6-2022
Insider Buy
James E. Sweetnam
Director
$11.30
CAGR »
$30,510.00
2,700 shares
11-30-2022
Insider Buy
Wood River Capital, LLC
>10% Owner
$9.50
CAGR »
$100,000,002.00
10,526,316 shares
5-12-2022
Insider Buy
Donald R. Young
President and CEO
$14.63
CAGR »
$73,150.00
5,000 shares
3-28-2022
Insider Buy
Industries Inc Koch
>10% Owner
$27.90
CAGR »
$49,999,993.37
1,791,986 shares
3-22-2022
Insider Buy
Robert M. Gervis
Director
$33.12
CAGR »
$4,500,014.40
135,870 shares
3-9-2020
Insider Buy
Donald R. Young
President and CEO
$7.18
CAGR »
$14,360.00
2,000 shares
5-9-2019
Insider Buy
Donald R. Young
President and CEO
$4.65
CAGR »
$23,250.00
5,000 shares
8-31-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$800.00
200 shares
8-9-2017
Insider Buy
Donald R. Young
President and CEO
$4.73
CAGR »
$4,731.60
1,000 shares
5-5-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$5,600.00
1,400 shares
5-4-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$3,164.00
791 shares
5-1-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$1,000.00
250 shares
4-26-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$25,220.00
6,305 shares
4-24-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$72,752.46
18,201 shares
4-20-2017
Insider Buy
Robert M. Gervis
Director
$3.99
CAGR »
$77,717.00
19,500 shares
4-18-2017
Insider Buy
Robert M. Gervis
Director
$3.99
CAGR »
$95,352.79
23,916 shares
4-13-2017
Insider Buy
Robert M. Gervis
Director
$3.99
CAGR »
$39,716.46
9,954 shares
4-12-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$21,602.00
5,401 shares
3-27-2017
Insider Buy
Robert M. Gervis
Director
$3.98
CAGR »
$796.00
200 shares
3-23-2017
Insider Buy
Robert M. Gervis
Director
$3.95
CAGR »
$31,267.52
7,912 shares
3-21-2017
Insider Buy
Robert M. Gervis
Director
$3.97
CAGR »
$28,182.00
7,100 shares
3-10-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$4,643.50
1,161 shares
3-6-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$400.00
100 shares
3-3-2017
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$4,663.90
1,166 shares
2-27-2017
Insider Buy
Robert M. Gervis
Director
$3.96
CAGR »
$163,623.60
41,285 shares
12-29-2016
Insider Buy
Robert M. Gervis
Director
$4.00
CAGR »
$1,600.00
400 shares
12-8-2016
Insider Buy
Donald R. Young
President and CEO
$4.20
CAGR »
$4,200.00
1,000 shares
8-24-2016
Insider Buy
William P. Noglows
Director
$4.98
CAGR »
$99,600.00
20,000 shares
8-23-2016
Insider Buy
Richard F. Reilly
Director
$4.82
CAGR »
$48,200.00
10,000 shares
8-10-2016
Insider Buy
Donald R. Young
President and CEO
$4.78
CAGR »
$10,994.00
2,300 shares
8-9-2016
Insider Buy
Mark L. Noetzel
Director
$4.74
CAGR »
$64,314.48
13,576 shares
5-12-2015
Insider Buy
Donald R. Young
President and CEO
$6.91
CAGR »
$17,275.00
2,500 shares
8-15-2014
Insider Buy
Donald R. Young
President and CEO
$10.28
CAGR »
$10,280.00
1,000 shares
6-18-2014
Insider Buy
Kaiser Family Foundation George
>10% Owner
$8.67
CAGR »
$27,177,882.88
3,134,965 shares
6-18-2014
Insider Buy
Craig A. Huff
Director and >10% Owner
$7.60
CAGR »
$21,525,934.38
2,831,045 shares
6-18-2014
Insider Buy
Donald R. Young
President and CEO
$11.00
CAGR »
$100,001.00
9,091 shares

Also See: Institutional Holders of ASPN
Also See: SEC filings

ASPN Performance Since Insider Purchase
Below we present the annualized performance delivered by Aspen Aerogels stock since 9-7-2023 (the date of the most recent insider purchase). The performance of the investment from the time Aspen Aerogels insider buying occurred is the ultimate test of whether insiders were right about ASPN being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/08/2023
End date: 04/17/2024
Start price/share: $6.33
End price/share: $15.07
Dividends collected/share: $0.00
Total return: 138.07%
Annualized Gain: 227.01%
Starting investment: $10,000.00
Ending investment: $23,807.00
Years: 0.61

Aspen Aerogels Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Aspen Aerogels insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ASPN

Quotes delayed 20 minutes

Email EnvelopeFree ASPN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the Aspen Aerogels Insider Buying occurred are:

Soleno Therapeutics Insider Buying
Dianthus Therapeutics Insider Buying
Southwest Gas Holdings Insider Buying
BitNile Metaverse Insider Buying
Pennymac Mortgage Investment Trust Insider Buying
Pyxis Oncology Insider Buying
Farmland Partners Insider Buying
Masco Insider Buying
Rubicon Technologies Insider Buying
Ocean Power Technologies Insider Buying

Aspen Aerogels Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.